Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Short term Debt (2022 - 2025)

Celularity (CELU) has disclosed Short term Debt for 4 consecutive years, with $92000.0 as the latest value for Q4 2025.

  • For Q4 2025, Short term Debt fell 96.3% year-over-year to $92000.0; the TTM value through Dec 2025 reached $92000.0, down 96.3%, while the annual FY2025 figure was $92000.0, 96.3% down from the prior year.
  • Short term Debt hit $92000.0 in Q4 2025 for Celularity, down from $4.3 million in the prior quarter.
  • Across five years, Short term Debt topped out at $39.3 million in Q3 2022 and bottomed at $92000.0 in Q4 2025.
  • Average Short term Debt over 4 years is $15.6 million, with a median of $14.0 million recorded in 2023.
  • Year-over-year, Short term Debt crashed 54.2% in 2023 and then tumbled 96.3% in 2025.
  • Celularity's Short term Debt stood at $37.6 million in 2022, then plummeted by 54.2% to $17.2 million in 2023, then crashed by 85.57% to $2.5 million in 2024, then crashed by 96.3% to $92000.0 in 2025.
  • According to Business Quant data, Short term Debt over the past three periods came in at $92000.0, $4.3 million, and $4.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.